Discover cutting-edge model selection strategies from West Coast biopharma and academic pioneers across models like organoids, xenografts, humanized models, and breakthrough modalities.
Network with experts in ADCs, bispecifics, degraders, cell therapy, and T-cell engagers advancing model translatability for faster, smarter preclinical pipelines.